The major research focus of the CDE department is directed toward describing and understanding the etiology of important diseases and disorders.

Ongoing research projects include:

  • Energy balance, risk of breast cancer and prognosis after breast cancer; investigating the complex roles of diet and physical activity
  • Folate, One-carbon metabolism and risk of colorectal and renal cancers
  • Prognostic importance of low social support and changes in social support for patient-centered outcomes after acute myocardial infarction
  • Nicotine Dependence: Psychiatric Co-occurrence and Impact on Quality of life
  • Noninvasive Measurement of Carotenoids in Human skin as a Biomarker of Fruit and Vegetable intake
  • Race Differences in the Eligibility for and receipt of carotid endarterectomy
  • Substance Abuse, HIV Infection, Medication Adherence and Mortality among a cohort of Aging US Veterans
  • Molecular Prognostic Markers in Cutaneous Malignant Melanoma
  • Effects of Demand and Control at Work on Depression and Ischemic Heart Disease Claims in a Heavy Industrial cohort
  • Exploring mechanisms potentially underlying racial/ethnic disparities in HIV and other Sexually transmitted infections using population-based data
  • Potential mediators of the relationship of late life job loss on health outcomes
  • Future expectations and adolescent sexual risk
  • Mobile technology as a tool to improve healthcare delivery
  • Maternal Health conditions and developmental delays in children: risks and health disparities for children in New York City

Recent Faculty Publications

Drahos J, Xiao Q, Risch HA, Freedman ND, Abnet CC, Anderson LA, Bernstein L, Brown L, Chow WH, Gammon MD, Kamangar F, Liao LM, Murray LJ, Ward MH, Ye W, Wu AH, Vaughan TL, Whiteman DC, Cook MB: Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium. Int J Cancer. 2016 Jan 1; 2015 Aug 26. PMID: 26175109

Killelea BK, Yang VQ, Wang SY, Hayse B, Mougalian S, Horowitz NR, Chagpar AB, Pusztai L, Lannin DR: Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Database. J Clin Oncol. 2015 Nov 23; 2015 Nov 23. PMID: 26598753

Harrigan M, Cartmel B, Loftfield E, Sanft T, Chagpar AB, Zhou Y, Playdon M, Li F, Irwin ML: Randomized Trial Comparing Telephone Versus In-Person Weight Loss Counseling on Body Composition and Circulating Biomarkers in Women Treated for Breast Cancer: The Lifestyle, Exercise, and Nutrition (LEAN) Study. J Clin Oncol. 2015 Nov 23; 2015 Nov 23. PMID: 26598750

Ligibel JA, Alfano CM, Hershman D, Ballard RM, Bruinooge SS, Courneya KS, Daniels EC, Demark-Wahnefried W, Frank ES, Goodwin PJ, Irwin ML, Levit LA, McCaskill-Stevens W, Minasian LM, O'Rourke MA, Pierce JP, Stein KD, Thomson CA, Hudis CA: Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement. J Clin Oncol. 2015 Nov 20; 2015 Aug 31. PMID: 26324364

Walsh KM, de Smith AJ, Hansen HM, Smirnov IV, Gonseth S, Endicott AA, Xiao J, Rice T, Fu CH, McCoy LS, Lachance DH, Eckel-Passow JE, Wiencke JK, Jenkins RB, Wrensch MR, Ma X, Metayer C, Wiemels JL: A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution. Cancer Res. 2015 Nov 15; 2015 Nov 2. PMID: 26527286

Shen Y, Wang Z, Loo LW, Ni Y, Jia W, Fei P, Risch HA, Katsaros D, Yu H: LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer. Breast Cancer Res Treat. 2015 Nov 13; 2015 Nov 13. PMID: 26564482